We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

53 hedge funds and large institutions have $25.7M invested in Vaxart in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

8% more funds holding

Funds holding: 4953 (+4)

12% less capital invested

Capital invested by funds: $29.1M → $25.7M (-$3.38M)

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
15
Reduced
12
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
+$270 +11 New
JFA
52
JNBA Financial Advisors
Minnesota
+$368 +15 New

VXRT Hedge Fund Activity: Q2 2015 in Review

53 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2015, worth a combined $25.7M — down 12% from $29.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VXRT positions and 5 closed out — a net gain of 4 holders — while 15 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $733K. The largest seller was RA Capital Management, cutting an estimated $1.33M.

  • 53 institutional investors held Vaxart (VXRT) as of Q2 2015, up from 49 in Q1 2015.
  • Funds reported $25.7M of Vaxart stock for Q2 2015, down 12% quarter-over-quarter.
  • 9 funds opened new Vaxart positions in Q2 2015 and 5 closed out, a net change of +4 holders.
  • The largest Vaxart buyer in Q2 2015 was Fidelity Investments, an estimated $733K added.
  • The largest Vaxart seller in Q2 2015 was RA Capital Management, an estimated $1.33M sold.

Based on aggregated 13F filings for Q2 2015.